Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up
Radiation Oncology Journal · 30.06.2026 · 44 (2) · 144-149
DOI: 10.3857/roj.2026.00108 ↗Kurz gefasst
Fallbericht in der Zeitschrift Radiation Oncology Journal, erschienen am 30.06.2026. Verfasst von Hung-Ruei Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heavy Particles and Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Sialoblastoma is a rare, aggressive pediatric salivary gland tumor often refractory to conventional therapies, which carry significant risks of growth impairment in children. We report the 52-month follow-up of a 6-year-old girl with recurrent sialoblastoma treated with two sessions of boron neutron capture therapy (BNCT). She achieved a 23-month complete response after the first session and a sustained partial response following the second. Dosimetric analysis using a conservative α/β ratio of 2.0 Gy for late-responding tissues showed that the equivalent dose in 2-Gy fractions to the mandible area was approximately 4.3 Gy-Eq. This is substantially below the 15 Gy threshold recognized for skeletal impairment. Our findings suggest that BNCT is a highly selective salvage option that effectively controls refractory pediatric tumors while preserving craniofacial development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Heavy Particles and Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
- Taipei Veterans General Hospital Neurosurgical Department, Division of General Neurosurgery, Taipei, Taiwan, R.O.C.
- Division of Pediatric Hematology and Oncology, Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
- Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
- Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu, Taiwan, R.O.C.
Zitieren
APA
Liao, H. R., Lee, Y. Y., Lee, C. Y., Chang, S. T., Lin, K. H., Chou, F. I., Peir, J. J., Liu, H. M., & Chen, Y. W. (2026). Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up. Radiation Oncology Journal, 44(2), 144-149. https://doi.org/10.3857/roj.2026.00108
Vancouver
Liao HR, Lee YY, Lee CY, Chang ST, Lin KH, Chou FI, et al. Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up. Radiation Oncology Journal. 2026;44(2):144-149. doi:10.3857/roj.2026.00108
BibTeX
@article{Liao2026,
author = {Liao, Hung-Ruei and Lee, Yi-Yen and Lee, Chih-Ying and Chang, Syuan-Ting and Lin, Ko-Han and Chou, Fong-In and Peir, Jinn-Jer and Liu, Hong-Ming and Chen, Yi-Wei},
title = {Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up},
journal = {Radiation Oncology Journal},
year = {2026},
volume = {44},
number = {2},
pages = {144--149},
doi = {10.3857/roj.2026.00108}
}
EUVIMED